by synergycap1 | Jul 21, 2017 | Bad Credit Loans, Bank Lending, Bringing Innovation to Market, Business Lending, Business Loans, Finance, Working Capital
Charitable giving by corporations is nothing new. Businesses have been donating goods and services to charities and not-for-profit organizations for years. What has changed is the approach, and how customers are reacting. Consider a company like Toms Shoes. It...
by synergycap1 | Jul 21, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
For the stock market, however, it could be the make-or-break week for earnings season, with more than a third of the S&P 500 companies and 13 Dow stocks reporting. FANG names— Facebook, Amazon and Alphabet — are among about 180 S&P companies...
by synergycap1 | Jul 21, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
NASHVILLE—Women hospital executives can start closing the pay gap with their male counterparts by truly negotiating compensation rather than accepting first offers, C-suite leaders said this week at the Modern Healthcare Women Leaders in Healthcare...
by synergycap1 | Jul 21, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Working Capital
The beginning of actual work on Caltrain’s long-awaited electrification project was celebrated Friday with gloating and rib-poking at the political opponents who staged a last-minute fight to block it.
by synergycap1 | Jul 21, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Icons of Entrepreneurship, Working Capital
Facebook CEO Mark Zuckerberg. CREDIT: Getty Images Jeff Bezos and Mark Zuckerberg, the founders and CEOs of Amazon.com and Facebook, respectively, have added a gob-smacking amount of money to their wealth in 2017 — more than $40 billion combined. Bezos and...
by synergycap1 | Jul 21, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
Drugmakers Baxter International and Claris Injectables agreed to divest two pharmaceutical products to settle Federal Trade Commission antitrust concerns over Baxter’s proposed $625 million acquisition of Claris’ injectable drugs business, the agency...
